AnaptysBio (NASDAQ:ANAB) Announces Quarterly Earnings Results

AnaptysBio (NASDAQ:ANAB – Get Free Report) issued its earnings results on Monday. The biotechnology company reported ($1.71) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.89) by ($0.82), Yahoo Finance reports. AnaptysBio had a negative net margin of 711.17% and a negative return on equity of 161.40%. The firm had revenue of […]

Leave a Reply

Your email address will not be published.

Previous post AllianceBernstein (NYSE:AB) Sees Large Volume Increase
Next post An early look at Bruins’ camp battles amid four major questions